Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Saturday 31.10.2020 at 7:00 AM CET
Settings

Settings

Goto Application

1. WO2007138998 - PHARMACEUTICAL COMPOSITION COMPRISING NITROGENATED FUSED CYCLIC COMPOUND

Publication Number WO/2007/138998
Publication Date 06.12.2007
International Application No. PCT/JP2007/060672
International Filing Date 25.05.2007
IPC
A61K 31/538 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
535having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
53751,4-Oxazines, e.g. morpholine
538ortho- or peri-condensed with carbocyclic ring systems
A61K 9/20 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, lozenges or tablets
A61K 9/28 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, lozenges or tablets
28Dragees; Coated pills or tablets
A61K 9/36 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, lozenges or tablets
28Dragees; Coated pills or tablets
30Organic coatings
36containing carbohydrates or derivatives thereof
A61K 31/404 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
403condensed with carbocyclic rings, e.g. carbazole
404Indoles, e.g. pindolol
A61K 31/47 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
47Quinolines; Isoquinolines
CPC
A61K 9/2018
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
2004Excipients; Inactive ingredients
2013Organic compounds, e.g. phospholipids, fats
2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
A61K 9/2077
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
2072characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
A61P 13/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13Drugs for disorders of the urinary system
02of urine or of the urinary tract, e.g. urine acidifiers
A61P 13/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13Drugs for disorders of the urinary system
12of the kidneys
A61P 19/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
02for joint disorders, e.g. arthritis, arthrosis
A61P 19/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
06Antigout agents, e.g. antihyperuricemic or uricosuric agents
Applicants
  • 日本たばこ産業株式会社 JAPAN TOBACCO INC. [JP]/[JP] (AllExceptUS)
  • 三木 一基 MIKI, Kazuki [JP]/[JP] (UsOnly)
  • 有元 冬紀 ARIMOTO, Fuyuki [JP]/[JP] (UsOnly)
  • 角南 正記 SUNAMI, Masaki [JP]/[JP] (UsOnly)
Inventors
  • 三木 一基 MIKI, Kazuki
  • 有元 冬紀 ARIMOTO, Fuyuki
  • 角南 正記 SUNAMI, Masaki
Agents
  • 高島 一 TAKASHIMA, Hajime
Priority Data
2006-14744026.05.2006JP
60/810,00801.06.2006US
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) PHARMACEUTICAL COMPOSITION COMPRISING NITROGENATED FUSED CYCLIC COMPOUND
(FR) COMPOSITION PHARMACEUTIQUE COMPRENANT UN COMPOSÉ AZOTÉ CYCLIQUE FUSIONNÉ
(JA) 窒素含有縮合環化合物含有医薬組成物
Abstract
(EN)
Disclosed is a pharmaceutical composition which is effective for the treatment or prevention of a disease associated with uric acid, such as hyperuricemia, tophus, acute gouty arthritis, chronic gouty arthritis, gouty kidney, urinary calculus, renal dysfunction, coronary disorder and ischemic heart disease, and which has excellent long-term stability and elution properties (disintegration properties). The pharmaceutical composition comprises a nitrogenated fused cyclic compound represented by the general formula [1] or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable additive, wherein the nitrogenated fused cyclic compound or the pharmaceutically acceptable salt thereof is not contacted with a basic additive. [1] wherein each symbol is as defined in the description.
(FR)
La présente invention concerne une composition pharmaceutique efficace pour le traitement ou la prévention d'une maladie associée à l'acide urique telle que l'hyperuricémie, le tophus, l'arthrite goutteuse aiguë, l'arthrite goutteuse chronique, le rein goutteux, les calculs urinaires, l'insuffisance rénale, les troubles coronariens ou la cardiopathie ischémique, ladite composition pharmaceutique ayant d'excellentes propriétés de stabilité à long terme et d'élution (propriétés de désintégration). La composition pharmaceutique comprend un composé azoté cyclique fusionné représenté par la formule générale [1] ou un de ses sels pharmaceutiquement acceptable et au moins un additif pharmaceutiquement acceptable, le composé azoté cyclique fusionné ou son sel pharmaceutiquement acceptable n'étant pas au contact de l'additif de base. [1] dans laquelle chaque symbole est tel que défini dans le mémoire descriptif.
(JA)
not available
Latest bibliographic data on file with the International Bureau